Applied Therapeutics: Shoshana Shendelman Steps Down as CEO, Les Funtleyder Appointed Interim CEO

Published on December 20, 2024

x) our ability to fund our working capital requirements and expectations regarding the sufficiency of our capital resources, (xi) the